This inventor holds 4 USPTO granted patents. Top assignee: Asahi Kasei Kogyo Kabushiki Kaisha. Active years: 1980-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fuji, JP (1980 - 1981)
- Numazu, JP (1983 - 1985)
Company Filing History:
Years Active: 1980-1985
Title: Kunihiko Ishii: Innovator in Antitumor Agents
Introduction
Kunihiko Ishii is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 4 patents to his name, Ishii's work is recognized for its potential impact on cancer treatment.
Latest Patents
Ishii's latest patents include innovative formulations of secalonic acid derivatives. One of his patents describes a secalonic acid derivative of the formula (I), where R is defined by specific chemical groups, including hydrogen atoms and alkyl groups. Another patent focuses on the method for preparing these secalonic acid derivatives, emphasizing their pharmaceutical applications and acceptable salts.
Career Highlights
Kunihiko Ishii is associated with Asahi Kasei Kogyo Kabushiki Kaisha, a prominent company in the chemical and pharmaceutical industry. His work at this organization has allowed him to explore and develop new therapeutic agents that could play a crucial role in cancer treatment.
Collaborations
Ishii has collaborated with notable coworkers, including Chisei Shibuya and Mitsuru Shibukawa. These partnerships have likely contributed to the innovative research and development of his patented compounds.
Conclusion
Kunihiko Ishii's contributions to the field of pharmaceuticals, particularly through his patents on secalonic acid derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in antitumor therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
